CA
GILD icon

Crewe Advisors’s Gilead Sciences GILD Stock Holding History

Crewe Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
1,032
+251
+32% +$33.1K 0.01% 292
2026
Q1 		$109K Buy
781
+50
+7% +$7K 0.01% 281
2025
Q4 		$89.7K Buy
731
+31
+4% +$3.77K 0.01% 297
2025
Q3 		$77.7K Sell
700
-26
-4% -$2.96K 0.01% 329
2025
Q2 		$80.5K Buy
726
+142
+24% +$15.1K 0.01% 244
2025
Q1 		$65.4K Sell
584
-531
-48% -$54.8K 0.01% 246
2024
Q4 		$103K Sell
1,115
-560
-33% -$50.4K 0.01% 204
2024
Q3 		$140K Buy
1,675
+5
+0.3% +$382 0.02% 187
2024
Q2 		$115K Sell
1,670
-254
-13% -$17K 0.01% 248
2024
Q1 		$141K Buy
+1,924
New +$148K 0.02% 225
2023
Q3 		– Sell
-1,133
Closed -$87.3K – 713
2023
Q2 		$87.3K Sell
1,133
-85
-7% -$6.78K 0.01% 214
2023
Q1 		$101K Sell
1,218
-130
-10% -$10.8K 0.01% 229
2022
Q4 		$116K Sell
1,348
-352
-21% -$27.9K 0.02% 204
2022
Q3 		$105K Buy
1,700
+677
+66% +$42.7K 0.02% 220
2022
Q2 		$63K Buy
1,023
+73
+8% +$4.52K 0.01% 266
2022
Q1 		$56K Sell
950
-6
-0.6% -$384 0.01% 220
2021
Q4 		$69K Buy
+956
New +$65.8K 0.01% 163
2020
Q4 		– Sell
-60
Closed -$4K – 538
2020
Q3 		$4K Buy
+60
New +$4.16K ﹤0.01% 395
2019
Q4 		– Sell
-417
Closed -$26K – 259
2019
Q3 		$26K Hold
417
– – 0.01% 150
2019
Q2 		$28K Hold
417
– – 0.01% 170
2019
Q1 		$27K Hold
417
– – 0.01% 146
2018
Q4 		$26K Sell
417
-400
-49% -$28K 0.01% 149
2018
Q3 		$63K Hold
817
– – 0.05% 103
2018
Q2 		$58K Hold
817
– – 0.05% 111
2018
Q1 		$62K Hold
817
– – 0.06% 98
2017
Q4 		$59K Buy
+817
New +$62K 0.06% 106

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Crewe Advisors's GILD Position: Q2 2026 in Review

Crewe Advisors increased its Gilead Sciences (GILD) stake by 32% in Q2 2026, buying an estimated $33.1K and bringing the position to 1,032 shares worth $130K. The position accounts for 0.01% of the portfolio, ranked #292.

Crewe Advisors first reported a position in GILD in Q4 2017 and has held it in 26 quarters since. The position peaked at $141K in Q1 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Crewe Advisors held 1,032 shares of Gilead Sciences worth $130K as of Q2 2026.
  • Crewe Advisors bought 251 Gilead Sciences shares in Q2 2026, an estimated $33.1K.
  • Gilead Sciences made up 0.01% of Crewe Advisors's portfolio in Q2 2026, its #292 holding.
  • Crewe Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 26 quarters since.
  • Crewe Advisors's Gilead Sciences position peaked at $141K in Q1 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.